openPR Logo
Press release

Lecithin & Phospholipids Market Analysis, Trends, Share, Growth, & Forecast to 2023

01-29-2019 02:05 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: MarketsandMarkets.com

MarketsandMarkets

MarketsandMarkets

The report "Lecithin & Phospholipids Market by Source (Soy, Sunflower, Rapeseed, Egg), Type (Fluid, De-Oiled, Modified), Application (Feed, Food (Confectionery Products, Convenience Food, Baked Goods) Industrial, Healthcare), and Region - Global Forecast to 2023" The global lecithin market was valued at USD 1.15 billion in 2018 and is projected to reach USD 1.59 billion by 2023, at a CAGR of 6.7% during forecast period. The global phospholipids market was valued at USD 3.23 billion in 2018 and is projected to reach USD 4.36 billion by 2023, at a CAGR of 6.2% during forecast period. The lecithin market is driven by factors such as increased demand from the feed segment, a shift in preference towards convenience foods in the emerging economies of the Asia Pacific and South American regions. On the other hand, the phospholipids market is driven by the increased demand for natural ingredients in personal care products and cosmetics in countries such as China, India, Japan, and South Korea.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=259514839

Based on type, the de-oiled type segment of the lecithin market is projected to grow at the highest CAGR during the forecast period

Based on type, the lecithin market has been segmented into de-oiled, fluid, and modified. The de-oiled segment is projected to grow at the highest CAGR during the forecast period. It offers benefits to manufacturers such as ease of handling since it is available in the powdered or granular form. It provides nutritional benefits to consumers and is used in dietary foods, bakery products, confectionery products, and convenience food. These are the key factors that drive the de-oiled segment in the lecithin market.

Based on source, the sunflower segment of the lecithin market is projected to grow at the highest CAGR during the forecast period

Based on source, the lecithin market has been segmented into soy, sunflower, rapeseed, and eggs while the phospholipids market is segmented into soy and egg. The sunflower segment is projected to grow at the highest CAGR during the forecast period. For food applications, the preferred lecithin is non-GMO lecithin, due to concerns about health issues related to the consumption of genetically modified products and strict regulations in regions such as Europe. The lecithin extracted from soy is generally GM; hence, end-user industries are switching to other options such as sunflower and rapeseed. The wide availability of sunflower in European countries such as Ukraine and Russia is also expected to favor the growth of the lecithin market in this region. 

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=259514839

In terms of application, nutrition & supplements segment is estimated to account for the largest share of the phospholipids value market in 2018

The nutrition & supplement segment is estimated to account for the largest share of the phospholipids market in 2018. The demand for phospholipids is growing in the developing economies of Asia Pacific, Eastern Europe, along with Africa, and the Middle East. Developing regions are expected to emerge as the fastest-growing consumers of phospholipids for pharmaceuticals and nutrition & supplement applications, due to the continuous increase in the per capita income in these regions and the increase in health awareness among consumers for natural ingredients.

The Asia Pacific region accounted for the largest share of the phospholipids market in 2017

The Asia Pacific region accounted for the largest share of the phospholipids market in 2017 market. Changes in consumer preference toward natural ingredients have increased the demand for phospholipid products. In Asia Pacific, a rise in the young population (under 30 years of age) and rising awareness about health have prompted consumers to opt for healthier alternatives such as food supplements. Furthermore, increased demand for bakery items such as cakes, pastries, and cookies will also drive the demand for lecithin in the region.

This report includes a study of the development strategies, along with the product portfolios of leading companies. It includes major players such as Cargill (US), ADM (US), Stern-Wywiol Gruppe (Germany), DowDuPont (US), and Bunge (US), who are focusing on expansions & investments, acquisitions, and agreements to strengthen their base in the lecithin & phospholipids market. Other players include Lipoid GmbH (Germany), Wilmar International (Singapore), Sonic Biochem Extractions (India), Avanti Lipids Polar (US), Lecico (Germany), VAV Life Sciences (India), Sodrugestvo (Luxembourg), Kewpie Corporation (Japan), Sojaprotein (Serbia), American Lecithin Company (US), Sime Darby Unimills, Lecital (Austria), and Lasenor Emul (Spain); these players are also strengthening their market position through expansions and new product launches.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lecithin & Phospholipids Market Analysis, Trends, Share, Growth, & Forecast to 2023 here

News-ID: 1542529 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are